N/A
N=134
Longitudinal Follow-up of High School Athletes
Elite Athlete · Healthy
Bottom Line
View on ClinicalTrials.gov: NCT02432183 ↗Enrolled (actual)
134
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: Maximal Fall in Forced Expiratory Volume in One-second (FEV1) After Eucapnic Voluntary Hyperventilation (EVH) Test — -4; -9; -9; -5 percentage of change in FEV1 after EVH — p=0.0061
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric · 11+ yrs
- Sex
- All
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Primary completion
- Jun 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Maximal Fall in Forced Expiratory Volume in One-second (FEV1) After Eucapnic Voluntary Hyperventilation (EVH) Test |
-4; -9; -9; -5 | 0.0061 sig |
| SECONDARY Number of Participants With Allergies Determined by Positive Skin Prick Test |
14; 6; 19; 4 | — |
Summary
In this study the investigators will study the lung function and airway inflammation in elite athletes starting at the elite sport school (age: 12-13 year) and the change in lung function parameters and airway inflammation after 1 and 2 years at the elite sport school in comparison to age-matched controls (exercising at a recreational level, <4 hours/week).
Eligibility Criteria
Inclusion Criteria
- Elite athletes from the elite sport school in Wilrijk and Leuven
- First grade of high school
Exclusion Criteria
- Performing >4hours/week sports
Data sourced from ClinicalTrials.gov (NCT02432183). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.